BPGAM
ANIK icon

BTG Pactual Global Asset Management’s Anika Therapeutics ANIK Stock Holding History

BTG Pactual Global Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6,654
Closed -$244K – 162
2014
Q3 		$244K Buy
+6,654
New +$288K 0.03% 191

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

BTG Pactual Global Asset Management's ANIK Position: Q4 2014 in Review

BTG Pactual Global Asset Management sold out of Anika Therapeutics (ANIK) in Q4 2014, closing a stake of 6,654 shares — an estimated $244K sold.

BTG Pactual Global Asset Management first reported a position in ANIK in Q3 2014 and held it in 1 quarter. The position peaked at $244K in Q3 2014. 160 funds tracked by Wall St. Rank hold ANIK as of Q4 2014.

  • BTG Pactual Global Asset Management reported no remaining Anika Therapeutics position as of Q4 2014 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 6,654 Anika Therapeutics shares in Q4 2014, an estimated $244K.
  • BTG Pactual Global Asset Management first reported a position in Anika Therapeutics in Q3 2014 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's Anika Therapeutics position peaked at $244K in Q3 2014.
  • 160 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2014.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.